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Abstract 
Prescription opioid abuse in the United States is an alarming health issue. In 2015, 
approximately 2 million people abused prescription opioids, and 12 million individuals 
misused their prescription opioid pain relievers. The percentage of individuals who died 
as a result of opiate abuse increased from 22% in 2013 to 76% in 2014. The purpose of 
this project was to evaluate the influence of an inner-city drug treatment (DTBF) program 
on opioid users’ behavior. The practice question addressed whether knowledge of signs 
and symptoms of opioid withdrawal obtained from the DTBF program resulted in a 
significant behavioral change in opioid use in 45 adults ages 18 to 25. The Centers for 
Disease Control and Prevention framework for program evaluation was used to guide the 
study. Data were collected using a pretest and posttest with the Clinical Opiate 
Withdrawal Scale (COWS) over a 6-month period. Results of t-test analysis indicated a 
significant change in drug use (p = .000). Recommendations to clinic administrators 
included encouraging all staff to use the COWS in screening individuals and observing 
them at each clinic visit. The implication of this study for social change is that findings 
may be used to reduce drug abuse and misuse among prescription opioid users. 
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Section 1: Nature of the Project 
The purpose of this project was to evaluate the impact of a 6-month inner-city 
drug treatment (DTBF) program on adults ages 18 to 25 using the Clinical Opioid 
Withdrawal Scale (COWS) (see Appendix). The COWS was used to assess the signs and 
symptoms of opioid withdrawal before and after participating in the drug treatment 
program. Drug abuse is a global epidemic affecting health, wealth, security, 
socioeconomic status, violence, and risky sexual behaviors leading to an increase in HIV 
and STD incidences (United Nations Office on Drugs and Crime, 2010). The epidemic of 
opioid abuse is important to address because of the negative effects on families, 
communities, and the United States. Drug abuse affects primarily young adults ages 18 to 
25 (Murthy, 2016). In 2015, two million people abused prescription opioids, and about 12 
million individuals misused their prescription opioid pain reliever (Murthy, 2016). In 
2014, there were 47,055 drug overdose deaths in the United States, and 28,647 (61%) 
were from opioids (Rudd, Aleshire, Zibbell, & Gladden, 2016). Drug overdoses in 
Maryland resulted in 1,259 deaths in 2015 and 1,468 deaths in 2016 (Maryland 
Department of Health and Mental Hygiene, 2017). Prescription and street drugs are 
causing the deaths of young adults because of deficient knowledge and drug seeking 
behaviors (Volkow, Frieden, Hyde, & Cha, 2014).  
The purpose of this project was to evaluate the DTBF program to assist 
stakeholders in identifying areas of improvement and to assess the impact of knowledge 
acquisition on behavioral changes among opioid users. The goal of the program was to 
decrease drug abuse and misuse as measured by a pretest and posttest with the COWS. 
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Section 1 presents the problem statement, purpose of the study, nature of the doctoral 
project, significance, and summary. 
Problem Statement 
Young adults often start drug use as a way to be socially connected with friends 
or groups of classmates who may be acquaintances. If the drug fills a valuable need, the 
abuser may continue using (Robinson, Smith, Saisan, & Shubin, 2017). As drug abuse 
takes hold of the abuser, it eventually consumes the abuser’s life. 
The purpose of this DNP project was to evaluate the effectiveness of an inner-city 
DTBF program. In spite of many community strategies and clinic implementations to 
reduce the alarming death rate related to opioid use, young adult drug abusers continue to 
experience an increase in the number of cases. The study site experienced a 64% increase 
in opioid drug overdose deaths in the first quarter of 2017, jumping from 113 in 2016 to 
176 in 2017 (Luttrell, 2017). The clinic developed an education program that included 
individual therapy sessions, drug education, and behavior modification education. The 
DTBF program welcomes young adults ages 18 to 25 who are using drugs. The program 
is facilitated twice a week by two rehabilitation therapists. This DNP project included 
pretest and posttest COWS data and de-identified data from the medical clinic records to 
compare participants’ knowledge before and after the program. The goal of the DTBF 
program was to achieve a safe and comfortable level of physical stability to address the 
psychological manifestations of withdrawal (American Addiction Centers, 2015). 
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Purpose Statement 
The purpose of this project was to evaluate the DTBF program to assist 
stakeholders in identifying areas of improvement, to assess the impact of knowledge 
acquisition on behavioral changes, and to reduce drug abuse and overdose deaths among 
adults ages 18 to 25 through use of the COWS. The project question was the following: 
Does participation in the DTBF program result in a decrease in participant-reported 
opioid drug use as measured by a pretest and posttest with the COWS? The DTBF 
program was open to young adults ages 18 to 25. The program was focused on behavioral 
modification enhancement through self-motivation and eagerness to resist old behaviors. 
Nature of the Doctoral Project 
The nature of this DNP project was an evaluation of the DTBF program and its 
effect on the reduction of opioid drug use by young adults in an inner-city medical clinic. 
The program evaluation followed the steps outlined for the evaluation of an existing 
quality improvement initiative in the DNP Manual for Quality Improvement Evaluation 
Projects. The project question was the following: Does participation in the DTBF 
program result in a decrease in participant-reported opioid drug use as measured by a 
pretest and posttest with the COWS? Databases for the program evaluation search 
included PubMed, Cochrane, CINAHL, and Medline. The Google Scholar search engine 
was also used.  
The COWS consists of 11 assessment questions. Participants completed the 
COWS at the first program class (January 2018) and at the final class 6 months later 
(June 2018). All pretest and posttest scores of participants who complete at least 85% of 
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the program were compared using paired samples t test. De-identified data were provided 
by the facility.  
Facilitators participating in the DTBF will complete an evaluation of the program. 
A report outlining the findings was presented to the clinic administrators and 
stakeholders. Recommendations for future programs based on evidence-based practices 
was be included. 
Significance 
The DTBF educational program for opioid drug users focuses on planned 
behavior modification that will result in a decrease in opiate drug use among the 
participants. The program includes evidence-based strategies for treating drug abusers 
including administration of the COWS. The program will help to positively impact the 
community by reducing opioid use, increasing cultural empowerment, increasing 
socioeconomic status, decreasing violence, and promoting behavioral modification 
changes. The DNP project will be important to those participants who volunteered to 
participate in the DTBF program by providing data on the effectiveness of the program 
and assisting stakeholders in identifying areas of improvement. Medical center staff 
responsible for implementation of the DTBF program will be given the opportunity to 
give input, evaluate the program, interpret results, disseminate evaluation findings, and 
assist stakeholders in identifying areas of improvement. 
The key stakeholders include community members and advocates, law 
enforcement personnel, drug treatment program staff, and health care professionals. A 
decrease in opioid-related visits to the clinic, emergency first facilities, and community 
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treatment programs will decrease the burden on the health care system. Findings from the 
study may also be used to reduce crime, imprisonment of abusers, and opioid-associated 
overdoses. The number of opioid overdoses may be reduced through participation in the 
educational program and increased awareness of drug abuse. The program helps to 
increase community awareness and reduce deaths from drug abuse in young adults. 
Summary 
Drug abuse is a severe health epidemic in the inner city where the project was 
conducted. The alarming increase in opioid-related deaths and treatment of opioid users 
places requires health care providers in the inner city to address and combat drug abuse 
problems. The purpose of this project was to evaluate the DTBF program to assist 
stakeholders in identifying areas of improvement, to assess the impact of knowledge 
acquisition on behavioral changes, and to reduce the use of drug abuse and overdose 
deaths among young adults ages 18 to 25 through use of the COWS. The project question 
was the following: Does participation in the DTBF program result in a decrease in 
participant-reported opioid drug use as measured by a pretest and posttest with the 
COWS?  
Section 1 introduced the problem and purpose of this project, the nature of the 
project and the significance of the project to social change. Section 2 addresses the 
concepts, models, and theories that are relevant to nursing practice. Included in Section 2 
are local background and context, the role of the DNP student, and role of the project 
team. 
6 
 
Section 2: Background and Context 
The DTBF program is administered by an inner-city medical clinic. The team of 
workers at the clinic associated with the drug program consists of the program 
administrator, counselors, interns, and stakeholders from other programs or services 
functioning within the clinic. The patients at the clinic are there voluntarily or court 
ordered with drug dependence behavior. Patients demonstrate little to no knowledge of 
the medical effects of opioid drugs and the consequences of long-term drug use. The 
clinic, which is located in an urban inner city in the southeast United States, observed a 
64% increase in opioid drug overdose deaths in the first quarter of 2017, jumping from 
113 in 2016 to 176 in 2017 (Luttrell, 2017). The clinic desired a quality assurance effort 
to determine whether their DTBF program promotes behavioral changes and leads to a 
decrease in drug use among program participants. The purpose of this project was to 
evaluate the DTBF program to assist stakeholders in identifying areas of improvement, to 
assess the impact of knowledge acquisition on behavioral changes, and to reduce drug 
abuse and overdose deaths among young adults through use of the COWS. The project 
question was the following: Does participation in the DTBF program result in a decrease 
in participant-reported opioid drug use as measured by a pretest and posttest with the 
COWS? 
Concepts, Models, and Theories 
Public health professionals strive to achieve health improvement. In 1999, the 
Centers for Disease Control and Prevention (CDC, 2017) developed a framework for 
program evaluation to ensure commitment to improving overall community health amidst 
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the complex transition in public health to achieve measurable health outcomes. As shown 
in Figure 1, there are six steps in the CDC framework: engage stakeholders, describe the 
program, focus the evaluation design, gather credible evidence, justify conclusions, and 
ensure use and share lessons learned (CDC, 2017). 
 
Figure 1. Conceptual framework of program evaluation in public health (CDC, 1999). 
Engage Stakeholders 
Public health work involves partnerships; the participants in the evaluation 
process for the current project are the inner-city medical clinic staff who are responsible 
for implementing the program. Stakeholders must be involved in the process to ensure 
that their perspectives are understood. When stakeholders are not fully participating in 
the evaluation, the project might not address important elements of the program’s 
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objectives, operations, and outcomes. The stakeholder roles include engaging in 
progressive inputs about proper evaluation of the participants, evaluating data collection 
tools, and interpreting the results. 
Describe the Program 
The DNP project should follow the mission and objectives of the program being 
evaluated (CDC, 2017). The DTBF program includes a clear and brief account of how to 
use the COWS to assess the knowledge of young adults regarding the signs and 
symptoms of opioid withdrawal. 
Focus the Evaluation Design 
The evaluation will include comparing the pretest and posttest results and the 
inner-city medical clinic archival results. The goal was to evaluate the differences and 
note the impact the DTBF program has on participants’ behavior modification. 
Gather Credible Evidence 
The participant data from the DTBF program from January to June 2018 was 
reviewed to determine the impact of the program on the knowledge of young adults 
regarding the signs and symptoms of opioid withdrawal. The DTBF program includes 
quantitative statistics to evaluate the data. Stakeholders completed evaluation of the 
program. 
Justify Conclusions 
The DTBF program results and recommendations was used to improve the 
program and educate more young adults regarding signs and symptoms of opioid 
withdrawal. 
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Ensure Use and Share Lessons Learned 
The DNP findings was communicated to the stakeholders. Recommendations 
based on evidence-based practices was included. 
Relevance to Nursing Practice 
According to the Centers for Disease Control and Prevention (2017), the groups 
most commonly affected by opioid abuse are those who have chronic pain conditions and 
those who are initially prescribed opioid pain medication for their chronic pain 
conditions. This epidemic is a widespread national problem, and opioid abuse occurs in 
both urban and suburban communities (Dasgupta, Beletsky, & Ciccarone, 2018). 
Dasgupta et al. (2018) stated that in attempts to address this national epidemic, there 
remain large health care disparities regarding chronic pain treatment and opioid 
addiction. Opioid abuse and overdose with opioid medications are higher in individuals 
who have lower socioeconomic status and education levels. Certain minority groups in 
the United States are also at a higher risk of opioid use and abuse. According to Dasgupta 
et al., “Native Americans are disproportionally affected by overdose deaths as are African 
Americans in Illinois, Wisconsin, Missouri, Minnesota, West Virginia, and Washington, 
DC, among other places” (p. 184). Over 41% of opioid overdose deaths occur in urban 
counties in the United States. Awareness and funding are being made available to combat 
this alarming situation.  
New pharmacological treatments are becoming available for the worldwide 
epidemic of heroin (diamorphine) abuse (Drugs & Therapy Perspectives, 2003). These 
treatments include drugs that either reduce opiate withdrawal symptoms during 
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detoxification or improve psychosocial equilibrium during maintenance therapy. Oral 
methadone maintenance remains the gold standard of pharmacotherapy for heroin 
dependence and is also used for managing withdrawal. The long-acting form of 
methadone can be administered on a less than daily schedule to patients who fail 
methadone maintenance.  
Buprenorphine is used for managing withdrawal and maintenance treatment. Both 
buprenorphine and naloxone have been introduced as an option for maintenance therapy. 
Clonidine and Lofexidine are nonopiate drugs used commonly for management of 
withdrawal symptoms. Lofexidine is suitable for use in outpatient settings because it is 
associated with fewer adverse effects. A long-acting opiate receptor antagonist, 
Naltrexone, has been used to accelerate opiate detoxification and as a maintenance agent. 
The medication used for withdrawal has its own side effects. 
Wiessing et al. (2017) discussed the historical development of successful 
epidemiological indicators of the quality of harm reduction services for monitoring and 
evaluation at international, national, and subnational levels. The aim was to improve 
these services to reduce health and social problems among people who use drugs, human 
immunodeficiency virus (HIV) and hepatitis C virus infection, crime and legal problems, 
overdose (death), and other morbidity and mortality. The framework was developed 
collaboratively using consensus methods involving nominal group meetings, review of 
existing quality standards, frequent e-mail communication, and qualitative analysis of 
opinions/experiences from a broad range of professionals/experts, members of civil 
society, and organizations representing people who use drugs. Twelve priority candidate 
11 
 
indicators were proposed for opioid agonist therapy (OAT), needle and syringe programs 
(NSP), and generic cross-cutting aspects of harm reduction services. Wiessing et al. 
concluded that the best practice indicators for monitoring harm reduction service will 
provide a structural basis for public health and epidemiological studies and support 
evidence- and human rights-based health policies, services, and interventions. Harm 
reduction, such as NSP and OAT, has helped in reducing harm from sharing needles. 
According to Samet and Fiellin (2015), the efforts in 90 countries having NSP programs 
and 80 having OAT programs have contributed to reductions in viral infections and other 
related comorbidities of drug abuse and addiction. 
Education, knowledge, and awareness of the signs and symptoms of drug abuse 
will encourage users to reduce use. The list and the mechanism of actions of the antidote 
of opioid withdrawal medication with the side effect of the Clonidine, lofexidine, 
Naltrexone, and Methadone will influence the drug user to reduce using secondary to the 
side effect of the antidotes. There are many variants and focuses of opioid withdrawal 
education, and that is why a guideline for the practice site was tailored to the target 
population. Considerations of the demographics of the target population, including 
education levels and cultural factors, were included in the guideline. Self-management 
was designed to encourage consumers to manage and notice their withdrawal symptoms, 
which will encourage them to be in charge of their health care needs. 
According to Brody (2017), of the 23.5 million teenagers and adults addicted to 
alcohol or drugs, only about 1 in 10 gets treatment, which often fails to keep them drug 
free. Many of these programs fail to use proven methods to deal with the factors that 
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underline addiction and set off relapse. According to recent examinations of treatment 
programs, most are rooted in outdated methods rather than newer approaches shown in 
scientific studies to be more effective in helping people achieve and maintain addiction-
free lives. People typically do more research when looking for personal items like a car 
than when seeking treatment for drug abuse. Health care providers are on the front line in 
disease prevention and treatment of drug addiction. Health care providers understand the 
risk factors for drug abuse, screen for risky substance use, intervene when needed, and 
diagnose, treat and manage drug abuse just as they do all other diseases (Center on 
Addiction, 2012). The COWS has been found to be one of the useful tools doctors and 
other health providers use to monitor the severity of withdrawal symptoms. These tools 
help in determining the next steps in opiate therapy detoxing treatment. The COWS tool 
is crucial because it allows the clinician to determine the time to begin administering the 
opiate blocker. If administered too soon, the blocker reacts, and the patient becomes sick 
quickly. The COWS is practical and beneficial because it indicates the level of dosing 
and how often it is required to maintain patients’ comfort and safety, mostly when opiate 
withdrawal problems can worsen medical conditions (Palarinus, 2018). 
Nursing Role in Drug Prevention 
Manworren and Gilson (2015) proposed nursing roles and interventions in 
educating families to reduce the occurrence and potentially fatal consequences of 
prescription opioid diversion. Manworren and Gilson presented three potential methods 
in which nurses can play a critical role: educating about the risks of opioid diversion, 
providing patients with ideas on the safekeeping and proper disposal of opioids, and 
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tracking patients’ analgesic use to improve knowledge of prescription analgesic 
requirements for pain management. Nurses are in a better position to help reverse the 
occurrence and potentially fatal consequences of prescription opioids due to their direct 
contact with patients. Manworren and Gilson discussed the magnitude of the problem of 
diversion, nonmedical use, and inappropriate storage and disposal of prescription opioids. 
Joranson and Gilsn (2005) analyzed Drug Enforcement Administration data from 
22 Eastern states between 2000 and 2003 and found that nearly 28 million dosage units of 
controlled substances were diverted in those states over that period, with six opioids 
(oxycodone, morphine, methadone, hydromorphone, meperidine, and fentanyl) 
representing nearly a quarter (roughly 6.5 million) of those dosage units. The National 
Institute on Drug Abuse reported that nearly 71% of diverted prescription drugs are 
obtained from a friend or relative, either for free (54.2%) or through theft or purchase 
(16.6%) (Substance Abuse and Mental Health Services Administration [SAMHSA], 
2014). Approximately 2.8 million people ages 12 and older reported using an illicit drug. 
About 20% of these cases involved the nonmedical use of prescription drugs, and about 
60% of these cases involved pain relievers. Nursing education is designed to reduce drug 
abuse. 
In 2016, opioid prescriptions and illicit drugs were the main driver of drug 
overdose deaths. Opioids were involved in 42,249 deaths in 2016, and opioid overdose 
deaths increased to 5 times higher in 2016 than 1999. The five states with the highest 
rates of death due to drug overdose were West Virginia (52.0 per 100,000), Ohio (39.1 
per 100,000), New Hampshire (39.0 per 100,000), Pennsylvania (37.9 per 100,000), and 
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Kentucky (33.5 per 100,000) (Griffiths (2017). This opioid epidemic calls for 
interventions from providers and nurses to combat the trends. Griffiths (2017) described 
ways that nurses can help reverse the trends through education. Every day, more than 
1,000 people are treated in emergency departments for misusing prescription opioids 
(Centers for Disease Control and Prevention (CDC 2017). Nurses can play an important 
role in reducing opioid overdose deaths by assessing and monitoring patients. In taking 
these steps, nurses can also protect themselves from possible legal action stemming from 
opioids drugs (Griffiths, 2017). 
Screening 
Nurses are well trained to detect patients with opioid abuse or misuse by using 
screening tools (National Institute on Drug Abuse, 2003). The national Institute on drug 
abuse (NIDA) was created to advance science on the causes and the consequences of 
drug use and addiction and apply the knowledge to improve individual, patients and 
public health. Nurses use the knowledge drive from NIDA to address the most 
fundamental and essential question about drug abuse trend. NIDA was a screening tool 
use by nurses to screen patient that uses substance. The NIDA-Modified ASSIST tool 
was found on the NIDA website https://www.drugabuse.gov/publications/resource-guide-
screening-drug-use-in-general-medical-settings/nida-quick-screen. The three steps are: 
1. Ask about past year drug use  
2. Begin the NIDA-Modified ASSIST: NIDA was a screening tool use by nurses 
to screen patient that uses substance 
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3. Score the NIDA-Modified ASSIST for illicit and nonmedical prescription 
drug use.  
Verify before patients begin taking NSAIDs, validate that they are not taking 
other anticoagulants, such as aspirin, and check for hepatic or renal impairment. The 
procedure to use for this pain management was available from the Institute for Clinical 
Systems Improvement (National Institute on Drug Abuse, 2003). The complete 
continuing education on courses in pain management was very efficient to nurses. 
Nurses need to educate patients about the role of pain medication in their care. 
This education should include pain medication options and the reasons why non-opioids 
are preferred. Education on how patients will dispose unused opioid medication was very 
necessary. If not disposed, it will be kept for future use and in so doing enhancing the 
behavior. 
Nurses are aware of referring patients to pain management beyond the acute phase 
need should be directed to another provider with this expertise (Griffiths, 2017), and 
documentation of the referral in the patient’s health record was necessary. Nurses who 
assess and monitor patients for withdrawal and treatment of pain are advised to be 
mindful of and have respect for their inherent abuse potential. In so doing, this protects 
patients from harm and nurses from potential liability. Using the knowledge acquired 
from Advance Practice Nursing helps to bridge the gap in creating awareness in patients 
who are in urgent need of reducing drug use. 
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Teaching Patients About the Risks of Opioid Diversion and Nonmedical Use 
Prescription medications should be taken only as prescribed. They should not 
be used for reasons other than those for which they are prescribed (for example, opioids 
should not be used to induce sleep). 
Medications are prescribed for only one person’s use. They should not be used 
by anyone other than the patient, even for the same indication. Sharing prescription 
medication was not only potentially dangerous, but it was also a federal crime in 
violation of the Controlled Substances Act. 
Provide controlled substance disposal education. Nurses should instruct 
patients to dispose of prescribed narcotics immediately when no longer needed and to 
provide information on safe and convenient disposal methods. The Drug Enforcement 
Administration identifies certain medications, including opioids, which are harmful 
because a single dose can be fatal if taken by someone other than the patient for whom 
the medication was originally prescribed. Disposal instructions for narcotics medications 
through flushing them down a sink or toilet (Joranson & Gilsn, 2005). 
Track opioid use. Nurses track opioid use through the following: 
• real-time data submission, 
• data access at the point of care, 
• integration with the electronic health record, 
• interstate data sharing, 
• expanded user access to data including the authorization of delegates, 
• data security and confidentiality maintenance, 
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• user education, and 
• development of valid patient risk scoring methods (Joranson & Gilsn, 2005). 
Inner City Treatment Program 
The inner-city treatment house was unique because it involves the following:, the 
individualized treatment, caring for co-occurring disorders, family involvement, and 
continuing care after Rehab and holistic philosophy of treatment. Research has shown 
that successful programs have specific features in common, like personalized treatment 
plans and evidence-based care. Incorporating drug use with the appropriate services was 
the key to a successful, long-term recovery in the inner-city treatment center. The 
treatment program was made to satisfied drug users experience, which will likely to 
promote compliance and desire to complete the program and transfer to a healthy 
lifestyle. 
Individualized treatment. Previously, all people seeking addiction treatment 
received same services at the rehab facility. The treatment involved all spectrum of life, 
adult, adolescent, man, woman, were assigned to the same therapies. The individual who 
could have been diagnosed with schizophrenia, addiction, and co-occurring disorders 
were expected to go through the same rehab without any specialized care for their mental 
health condition. The inner-city treatment center provides a personalized treatment. The 
program treats each client as an individual, with a unique history and specific needs. The 
treatment developed a personalized care plan which begins with a complete evaluation of 
the prospective individual before the admission. 
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Care for co-occurring disorders. The treatment involves psychiatric conditions 
and addiction because the two frequently occur together in patients, this treatment center 
recognizes the phenomenon and provide integrated care for their patients with co-
occurring disorders. It was vital to screen for a co-occurring mental health disorder to get 
connected with a good treatment program. 
Family involvement. The involvement with family members and excellent 
support system make the program useful. Without the support and participation of family 
members, chances of success at rehab are significantly reduced (Michael house treatment 
center, 2018). 
Continuing care after rehab. What makes the program unique was the 
continuation of care after rehab. The program ensures that rehab graduates have the 
support they need to stay sober after leaving the secure, structured environment of the 
inner- city program. 
Holistic philosophy of treatment. The inner-city treatment program, care for 
individuals holistically, the center considers the patients entire being when implementing 
a recovery plan. The holistic philosophy of care increases the chances of success in 
helping heal on all levels. Inner-city treatment house is exceptionally equipped to offer 
holistic drug treatment. The program treated each individuals as worthy of dignity, 
compassion, and respect. 
Prescription drug monitoring. Another successful community program was the 
prescription drug monitoring programs (PDMPs). The aim of PDMPs are geared towards 
primary prevention to monitor improper prescription of opioid painkillers which was a 
19 
 
primary upstream driver of opioid epidemic while ensuring critical pain issue was address 
as necessary (Davis, Green, & Beletsky, 2017; Volkow et al., 2014). PDMPs are 
promising tool for health care provider to see patients prescribing histories to inform their 
prescribing decisions. The drug users, shop pain medications from one physician to 
another with the aim to misuse medication. The use of PDMPs help to reduce the overly 
prescription of pain pills (Davis, C. et al., 2017). In Rhode Island, they adopted PDMPs, 
three years later, their opioid overdose deaths dropped by one-third. 
Local Background and Context 
The state where the inner-city medical clinic was located experienced a 67% 
increase in opioid drug associated overdose deaths in 2017 (Maryland Department of 
Health and Mental Hygiene, 2017). The DNP project was chosen based on the need of 
the patients at the project site and the alarming increase in young adult abuse of drugs. 
The inner-city medical clinic was comprised of an administrator, psychiatrist, two 
counselors, and a house specialist. The clinic has a population of 30 to 45 participants 
who come for therapy. The demographic makeup of the patients is estimated to be 50% 
Caucasian, 45% African American, 3% Hispanic, and 1% Asian American. Their 
population was both young and old adults, males, females, and all races. The issue being 
addressed in this project was the effect of opioid abuse in young adults aged 18 to 25 in 
the inner-city medical clinic. The program was held every Tuesday and Thursday, and 
two rehabilitation therapists facilitate the program. The program starts at 9:00 a.m. and 
ends at 2:00 p.m. The inner-city medical clinic was using the DTBF program to reach out 
to the participants who need help with reducing drug use by using methodologies such as 
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the medication-assisted treatment (MAT) program, prescription drug monitoring program 
(PDMP), and training the neighbors, police officers, and communities on how to apply 
Narcan antidote for opioid overdoses to consumers in the community. 
Addressing the following was recommended by the American Public Health 
Association (2015). Regulate prescription pain medication, and review and revise 
prescription drug monitoring laws, doctor shopping laws, and physical and mental status 
examination laws. Implement tamper-resistant prescription form requirements, 
prescription drug overdose emergency response immunity, and provide access to 
Naloxone (American Public Health Association, 2015). 
Even with new legislative policy changes, community education energies could 
be centered on ensuring safe storage, use, and disposal of prescription medications. 
Individuals taking prescription pain medication must be educated on the identification 
and treatment of pain. In addition, alternative pain treatment, substance abuse screening, 
and mental illness assessment and treatment for vulnerable populations must be provided. 
Role of the DNP Student 
I observed in this clinic as part of my DNP practicum. The medical director 
expressed that the clinic’s goal was not only to provide needed services to the 
community, but to ensure that the services provided were implemented effectively both in 
cost and desired outcomes. She instituted the DTBF program, and as part of her quality 
improvement focus, requested an evaluation of the program. My role as the DNP student 
was to complete the program evaluation. 
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Role of the Project Team 
There are 45 participants in the program. The program facilitator administered the 
COWS and provide de-identified data to me for the program evaluation. 
Summary 
The relevance of this project to nursing practice was the assessment of the drug 
program implementation at the inner-city medical clinic to reduce opioid drug abuse, 
preventing opioid abuse overdose, decreasing frequent visits to emergency facilities for 
pain relief and opioid type medication, and the prevention of pain medicine addictions. 
As an evaluation of the drug program and the outcome of this project, the DTBF drug 
program can be implemented throughout the inner-city medical clinic, even in the school 
system reaching youth as young as age 12. The nurse practitioner can see cost-effective 
results through the reduction of opioid related caseloads, medication theft and misuse, 
and premature death of young adults aged 18-25 by overdose of opioid drugs. As a 
quality assurance effort, the nurse practitioner can build on their drug program by 
strengthening weak areas of program delivery services. 
Section 2 describes the CDC Program Evaluation for Public Health Model and the 
application of the model to this project. The evidence-based literature relevant to the 
project was discussed. My role and the role of the facilitator are described. Section 3 
discusses the sources of the evidence provided by the facility, participants, procedures, 
and protections, and the analysis and synthesis for the project. 
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Section 3: Collection and Analysis of Evidence 
The DNP project study addressed the effects of opioid abuse in young adults ages 
18 to 25 in a medical clinic located in an inner city. Section 3 includes the sources of 
evidence provided by the facility. I also describe the participants, procedures, and 
protections, and present the analysis and synthesis for the project. 
Practice-Focused Question 
The purpose of this project was to evaluate the DTBF program to assist 
stakeholders in identifying areas of improvement, to assess the impact of knowledge 
acquisition on behavioral changes, and to reduce drug abuse and overdose deaths among 
young adults through use of the COWS. The project question was the following: Does 
participation in the DTBF program result in a decrease in participant-reported opioid drug 
use as measured by a pretest and posttest with the COWS. 
Sources of Evidence 
The inner-city clinic staff retrieved data from the information center using 
Amazing chart information technology system with the assistance of medical records 
personnel and authorized by the owner and medical director of the inner-city medical 
center. 
Participants 
The inner-city medical clinic has a population of up to 45 participants who come 
for therapy. The population was composed of 50% White, 45% African American, 3% 
Hispanic, and 1% Asian American. Participants in this project must 
• have experienced using opioid drugs or opioid pain medicine; 
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• have been between the ages of 18 and 25; 
• have been enrolled in the DTBF drug education program held at the inner-city 
medical clinic; and 
• have taken an assessment test on their knowledge of drug addiction and 
withdrawal, and scored 80 or below. 
Procedures 
The program evaluation was completed using the steps for the evaluation of 
existing quality improvement initiatives outlined in the DNP Manual for Quality. 
Qualifying participants were selected and given the COWS (Appendix A) before 
attending the 6-month DTBF program and again after completion of the DTBF program. 
The COWS was available on the Internet and may be copied and used clinically. De-
identified data were provided to me from the program facilitator. Data will be stored in a 
locked cabinet at the facility for a period of 3 years after the program evaluation is 
completed. A paired samples t test using SPSS was conducted on the data as well as the 
total mean for pretest and posttest data. Participants also completed an evaluation of the 
program. Results were reviewed and used for quality improvement recommendations. 
Protections 
A site approval letter for quality improvement doctoral projects from the DNP 
Manual for Quality Improvement Evaluation Projects was obtained from the clinic 
administrator. The signed site approval letter and completed institutional review board 
(IRB) application was submitted to the (Walden University IRB). 
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Analysis and Synthesis 
The data analysis included a paired samples t test and review of the program 
evaluations. Pretest and posttest data were analyzed to determine whether education on 
the signs and symptoms of opioid withdrawal using the COWS made a significant 
difference (p = .05). 
Summary 
The purpose of this project was to evaluate the DTBF program to assist 
stakeholders in identifying areas of improvement, to assess the impact of knowledge 
acquisition on behavioral changes, and to reduce the drug abuse and overdose deaths 
among young adults through use of the COWS. The project question was the following: 
Does participation in the DTBF program result in a decrease in participant-reported 
opioid drug use as measured by a pretest and posttest with the COWS? Section 3 
identified the data used for this program evaluation, including the participants, 
procedures, protections, and how the data were analyzed and reported. 
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Section 4: Findings and Recommendations 
The effects of drug abuse on young adults ages 18 to 25 are alarming (Murthy, 
2016). In 2015, two million people abused prescription opioids, and about 12 million 
individuals misused their prescription opioid pain reliever (Murthy, 2016). Drug abuse 
affects mostly young adults ages 18 to 25. The epidemic is comprehensive, affecting 
young and old, male and female (Murthy, 2016). The drug abuse crisis has claimed many 
lives in the study site community with social and economic impacts to the area. Volkow 
et al. (2014) reported that prescription and street drugs are causing the deaths of young 
adults because of insufficient knowledge and drug-seeking behaviors.  
The purpose of this project was to evaluate the DTBF program to assist 
stakeholders in identifying areas of improvement, to assess the impact of knowledge 
acquisition on behavioral changes, and to reduce the drug abuse and overdose deaths 
among young adults through use of the COWS. Social change implications include a 
decreased number of opioid overdoses resulting from individuals participating in the 
educational program and increasing their awareness of drug abuse. 
Findings and Implications 
The objective of this project was to answer the following question: Does the 
knowledge of signs and symptoms of opioid withdrawal from participating in the DTBF 
program result in a significant behavioral change of opioid abuse in young adults ages 18 
to 25 as measured by a pretest and posttest with the COWS? Results of a paired samples t 
test (N = 45) revealed a significant change in the results of the COWS survey at a 95% 
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confidence level. This result indicated a significant improvement in drug use behavior 
among participants, as shown in Table 1. 
Table 1 
Paired Samples T Test 
________________________________________________________________________ 
Mean Std. Deviation  Std. Error Mean   Lower Upper       t      df   Sig (2-tailed) 
6.111 5.74146 .85589        4.38618 7.83604    7.140   44       .000  
 
Recommendations 
The rising prevalence of opioid drug abuse and overdose was causing a significant 
threat to the population in and around the inner-city community. The clinic should train 
all staff members to use the COWS in screening patients and observing them at every 
visit. Clients who demonstrate little or no improvement in their COWS scores can be 
offered pain management treatment over prescribed pain medicine. 
Strengths and Limitations of the Project 
The inner-city clinic staff participated in the project and acted independently from 
any external influences; there was no conflict of interest. The project included evidence-
based recommendations from accredited organizations such as the Centers for Disease 
Control and Prevention and SAMHSA. The COWS instrument is a reliable and valid tool 
that can be easily administered at each client encounter. The strengths of the project 
included a large number of respondents; 45 of 45 participants responded. The location of 
the project site was centralized, which enhanced access to transportation. The formative 
group and summative group included patients who were court committed and health care 
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counselors who had several encounters with opioid abuse. Participants who were not 
health care providers contributed knowledge from the layperson’s point of view, gave 
suggestions on how to improve the wording and formatting of opioid management 
education, and provided recommendations on the method of implementation. 
Although the COWS was a useful tool, drug use was a complex phenomenon, and 
the COWS tool may not be robust enough to explain complex issues. The time duration 
was limited, from January to June 2018. One of the problems of the study was to 
maintain 80% attendance required for eligibility. Some participants came late to the 
program because of transportation issues. The sample size was limited and there was no 
follow-up after the 6-month period. 
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Section 5: Dissemination Plan 
The purpose of this project was to evaluate the impact of a 6-month inner-city 
DTBF program for young adult ages 18 to 25 using the 11 items of the COWS 
instrument. Comparison of pretest and posttest data revealed a significant difference in 
the scores of the COWS. The project and the results of the COWS was presented to the 
clinic providers. The presentation occurred during the midday. The presentation included 
charts, posters, graphs, data, and samples of the questionnaires. 
Analysis of Self 
The nursing profession involves engagement in the development and promotion 
of new approaches to nursing practice. Because of the alarming rate of opioid abuse rate 
in the inner city, I conducted this study to reduce the number of deaths related to opioid 
drug abuse and misuse. As a DNP student, I have a duty to advance the practice of 
nursing, provide the possible best treatment to patients, and improve consumers’ health 
outcomes through evidence-based treatment guidelines. My knowledge of the DTBF 
project will greatly assist the stakeholders in identifying areas of improvement, assessing 
the impact of DTBF program on behavioral changes, and planning long-term professional 
health care policies. My knowledge of the DTBF project will lead to a more 
comprehensive assessment of health issues in a complex and large health care institution. 
I applied scholarly methodology with the goal of improving health care outcomes, 
improving an organizational process, improving workplace and consumer satisfaction, 
and implementing health care policies to promote education regarding opioid use.  
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I supported the staff, counselors, facilitators, and interns in collaborating with 
stakeholders to implement the new practice change. 
Summary 
The purpose of this DNP project was to improve a practice within an organization 
and to gain insight in the effectiveness of the practice change. The DTBF project was 
effective because of the moderate impact on consumers’ behavior regarding opioid drug 
use. The outcome of the project was disseminated through poster presentations and visual 
presentations. 
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Appendix: Clinical Opiate Withdrawal Scale 
For each item, circle the number that best describes the patient’s signs or symptom. Rate on just the 
apparent relationship to opiate withdrawal. For example, if heart rate is increased because the patient 
was jogging just prior to assessment, the increase pulse rate would not add to the score 
Resting Pulse Rate: beats/minute 
Measured after patient is sitting or lying for one minute 
0 pulse rate 80 or below 
1 pulse rate 81- 1 00 
2 pulse rate 101-1 20 
4 rate than 1 20 
GI Upset: over last 1/2 hour 
0 no GI symptoms 1 
stomach cramps 
2 nausea or loose stool 
3 vomiting or diarrhea 
5 of diarrhea or 
Sweating: over past 1/2 hour not accounted for by 
room temperature or patient activity. 
0 no report of chills or flushing 
1 subjective report of chills or flushing 
2 flushed or observable moistness on face 
3 beads of sweat on brow or face 
4 sweat off face 
Tremor observation of outstretched hands 
0 no tremor 
1 tremor can be felt, but not observed 
2 slight tremor observable 
4 gross tremor or muscle twitching 
Restlessness Observation during assessment 
0 able to sit still  
1 reports difficulty sitting still, but is able to do so 
3 frequent shifting or extraneous movements of legs/arms 
5 unable to sit still for more than a few seconds 
Yawning Observation during assessment 
0 no yawning 
1 yawning once or twice during assessment 
2 yawning three or more times during assessment 
4 several times/minute 
Pupil size 
0 pupils pinned or normal size for room light 
1 pupils possibly larger than normal for room light 
2 pupils moderately dilated 
5 pupils so dilated that only the rim of the iris is visible 
Anxiety or Irritability 
0 none 
1 patient reports increasing irritability or anxiousness 
2 patient obviously irritable or anxious 
4 patient so irritable or anxious that participation in the 
assessment is difficult 
Bone or Joint aches if patient was having pain 
previously, only the additional component attributed 
to opiates withdrawal is scored 
0 not present 
1 mild diffuse discomfort 
2 patient reports severe diffuse aching of joints/muscles 
4 patient is rubbing joints or muscles and is unable to sit still 
because of discomfort 
Gooseflesh skin 
0 skin is smooth 
3 piloerection of skin can be felt or hairs standing up 
on arms 
5 prominent piloerection 
Runny nose or tearing Not accounted for by cold 
-symptoms or allergies 
0 not present 
1 nasal stuffiness or unusually moist eyes 
2 nose running or tearing 
4 nose constantly running or tears streaming down cheeks 
 
Total Score 
The total score is the sum of all 1 1 items 
Initials of person 
completing assessment: 
 
Score: 5- 12 = mild; 13-24 = moderate; 25-36 = moderately severe; more than more than  36 = severe withdrawal this version 
may be copied and used clinically.  
